SABS Competitors & Alternatives
Compare SAB Biotherapeutics Inc with similar stocks in the same industry
Biotechnology
SABS
Main Stock$3.33
Tradestie Score
50
Market Cap
$20.61M
Revenue Growth
-0.6%
Analyst Upside
+203.3%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$8.56
|
$304.12M | - | 59 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$15.34
|
$297.23M | - | 50 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$30.28
|
$293.03M | - | 56 | Compare |
|
OMER
Omeros Corporation
|
$8.74
|
$281.75M | 8.9 | 48 | Compare |
|
DBVT
DBV Technologies S.A.
|
$17.42
|
$275.54M | - | 57 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$1.90
|
$275.13M | - | 48 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$14.36
|
$269.08M | - | 55 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$7.83
|
$211.22M | - | 55 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.32
|
$202.58M | - | 54 | Compare |
More SABS Analysis
Data updated: Jun 13, 2026 | Industry: Biotechnology (SIC 2836)
225 stocks in this industry